Evidence map›Paper›PMID 18280792›Full record

ArticleClinical immunology (Orlando, Fla.)2008

Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells.

Chaorui Tian, Xueli Yuan, Jessamyn Bagley, Bruce R Blazar, Mohamed H Sayegh, John Iacomini

Open access · greenAbstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Transplantation tolerance through mixed chimerism.Nature reviews. Nephrology · 2010
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Chaorui TianTransplantation Research Center, Brigham and Women's Hospital and Children's Hospital Boston, Harvard Medical School, 221 Longwood Avenue LM303, Boston, MA 02115, USA.
Xueli Yuan
Jessamyn Bagley
Bruce R Blazar
Mohamed H Sayegh
John Iacomini
Brigham and Women's Hospital · USHarvard University · USUniversity of Minnesota Medical Center · US

Funding

Transgenic/KnockoutP01AI056299 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BLAZAR, BRUCE R · 2003 to 2023
$42.5M
Arming the Immune System Against PathogensP01AI056296 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GLIMCHER, LAURIE HOLLIS · 2003 to 2007
$20.0M
T Cell Fate as a Determinant of Alloimmune ResponsesP01AI041521 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI STROM, TERRY B. · 1997 to 2011
$15.9M
Nontoxic Strategies to Establish Allochimerism in MiceR01HL063452 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BLAZAR, BRUCE R · 1999 to 2012
$4.3M
TOLERANCE TO ALLOGRAFTS THROUGH GENE THERAPYR01AI043619 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI IACOMINI, JOHN J · 1998 to 2008
$2.4M
Using natural antibodies to improve vaccinesR01AI083459 · NIAID · TUFTS UNIVERSITY BOSTON · PI IACOMINI, JOHN J · 2010 to 2014
$2.2M
Induction of Tolerance using T cells to Deliver AntigenR01AI070601 · NIAID · TUFTS MEDICAL CENTER · PI IACOMINI, JOHN J · 2007 to 2011
$1.9M
Activating Alloreactive T CellsR01AI053666 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI IACOMINI, JOHN J · 2003 to 2007
$1.6M
NHLBI NIH HHS R01 HL063452NHLBI NIH HHS R01 HL63452NIAID NIH HHS P01 AI041521NIAID NIH HHS P01 AI056296NIAID NIH HHS P01 AI056299NIAID NIH HHS R01 AI043619NIAID NIH HHS R01 AI053666NIAID NIH HHS R01 AI070601NIAID NIH HHS R01 AI083459
6 · The paper itself

Abstract

The observation that bone marrow derived hematopoietic cells are potent inducers of tolerance has generated interest in trying to establish transplantation tolerance by inducing a state of hematopoietic chimerism through allogeneic bone marrow transplantation. However, this approach is associated with serious complications that limit its utility for tolerance induction. Here we describe the development of a novel approach that allows for tolerance induction without the need for an allogeneic bone marrow transplant by combining non-myeloablative host conditioning with delivery of donor alloantigen by adoptively transferred T cells. CBA/Ca mice were administered 2.5 Gy whole body irradiation (WBI). The following day the mice received K(b) disparate T cells from MHC class I transgenic CBK donor mice, as well as rapamycin on days 0-13 and anti-CD40L monoclonal antibody on days 0-5, 8, 11 and 14 relative to T cell transfer. Mice treated using this approach were rendered specifically tolerant to CBK skin allografts through a mechanism involving central and peripheral deletion of alloreactive T cells. These data suggest robust tolerance can be established without the need for bone marrow transplantation using clinically relevant non-myeloablative conditioning combined with antigen delivery by T cells.

Indexed as

Adoptive TransferAnimalsChimerismFemaleGraft SurvivalImmunosuppressive AgentsIsoantigensMiceMice, Inbred BALB CMice, Inbred CBAMice, TransgenicSirolimusSkin TransplantationT-LymphocytesTransplantation ToleranceWhole-Body IrradiationImmunosuppressive AgentsIsoantigensSirolimus

Identifiers

PMID18280792
PMCPMC2430039
OpenAlexW2070488421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.